Variant report
Variant | esv3423015 |
---|---|
Chromosome Location | chr2:231426560-231426972 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs35637946 | chr2:231426564-231426565 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs77635808 | chr2:231426575-231426576 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs62195486 | chr2:231426580-231426581 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs571112171 | chr2:231426590-231426591 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs181866142 | chr2:231426611-231426612 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs530272512 | chr2:231426634-231426635 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs186937186 | chr2:231426683-231426684 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs566538638 | chr2:231426729-231426730 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs190425648 | chr2:231426736-231426737 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs539704746 | chr2:231426810-231426811 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs145961316 | chr2:231426878-231426879 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs182496580 | chr2:231426899-231426900 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs113445425 | chr2:231426900-231426901 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs570121243 | chr2:231426909-231426910 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs139921823 | chr2:231426937-231426938 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs202170739 | chr2:231426949-231426950 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs67439016 | chr2:231426956-231426957 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs1616037 | chr2:231426958-231426959 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs554674692 | chr2:231426960-231426961 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs572977643 | chr2:231426962-231426963 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs540313078 | chr2:231426964-231426965 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs76157442 | chr2:231426966-231426967 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cervical cancer | 21062161 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chordoma | 18071362 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Cancer | 22429812 | CNVD |
Bladder cancer | 21909424 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Mental retardation | 20152051 | CNVD |
Cancer | 21183584 | CNVD |
Albright''s disease | 22277900 | CNVD |
Brachydactyly-Mental Retardation Syndrome | 22470819 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Autism | 18414403 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:231401000-231430200 | Weak transcription | Pancreas | Pancrea |
2 | chr2:231410200-231428800 | Weak transcription | Primary B cells from cord blood | blood |
3 | chr2:231426600-231427200 | Enhancers | Primary B cells from peripheral blood | blood |